Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Orthofix Intl NV
(NQ:
OFIX
)
13.60
+0.36 (+2.72%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Orthofix Intl NV
< Previous
1
2
3
4
5
Next >
Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
April 23, 2024
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Names Andres Cedron as New Chief Legal Officer
April 16, 2024
From
Orthofix Medical Inc.
Via
Business Wire
Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer
March 18, 2024
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Medical Inc. (NASDAQ:OFIX) Investor Alert: Investigation over Potential Wrongdoing
November 02, 2023
San Diego, CA -- (SBWIRE) -- 11/02/2023 -- Certain directors of Orthofix Medical Inc are under investigation over potential breaches of fiduciary duties.
Via
SBWire
Orthofix Reports Fourth Quarter and Full Year 2023 Results
March 05, 2024
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Announces New President for Bone Growth Therapies Business
February 29, 2024
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024
February 21, 2024
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Announces Commercial Partnership with MRIguidance
January 18, 2024
From
Orthofix Medical Inc.
Via
Business Wire
Julie Andrews Begins as New Chief Financial Officer at Orthofix
January 16, 2024
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results
January 09, 2024
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer
January 08, 2024
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis
December 21, 2023
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics Company
December 12, 2023
From
Orthofix Medical Inc.
Via
Business Wire
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
December 10, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
November 29, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Orthofix Medical Inc. (NASDAQ: OFIX) for Potential Breaches of Fiduciary Duty by Its Board of Directors
November 29, 2023
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Orthofix Announces Publication in The Spine Journal of Five-Year Data for the M6-C Artificial Cervical Disc
November 29, 2023
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Names Massimo Calafiore as President and Chief Executive Officer
November 28, 2023
From
Orthofix Medical Inc.
Via
Business Wire
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
November 24, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
November 13, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
November 08, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Orthofix Reports Third Quarter 2023 Results
November 08, 2023
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Announces Full Commercial Launch of the WaveForm L Interbody System for Lateral Lumbar Fusion Procedures
November 06, 2023
From
Orthofix Medical Inc.
Via
Business Wire
ORTHOFIX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options
November 04, 2023
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
November 03, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Orthofix, Dollar, and Clorox and Encourages Investors to Contact the Firm
October 29, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Viasat, Veradigm, and Orthofix and Encourages Investors to Contact the Firm
October 23, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Scynexis and Encourages Investors to Contact the Firm
October 18, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 8, 2023
October 18, 2023
From
Orthofix Medical Inc.
Via
Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Dollar and Encourages Investors to Contact the Firm
October 13, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.